|
gptkbp:instanceOf
|
hormon
|
|
gptkbp:approvedBy
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:CASNumber
|
58-22-0
|
|
gptkbp:category
|
hormone
endocrine system
sex hormone
|
|
gptkbp:chemicalFormula
|
C19H28O2
|
|
gptkbp:class
|
anabolic steroid
androgen
|
|
gptkbp:discoveredBy
|
gptkb:Ernst_Laqueur
|
|
gptkbp:discoveredIn
|
1935
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:foundIn
|
humans
mammals
|
|
gptkbp:function
|
development of male reproductive tissues
growth of body hair
promotion of secondary sexual characteristics
increase of muscle and bone mass
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Testosteron
|
|
gptkbp:IUPACName
|
17β-hydroxyandrost-4-en-3-one
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:meltingPoint
|
155 °C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
288.42 g/mol
|
|
gptkbp:predecessor
|
gptkb:estradiol
gptkb:dihydrotestosterone
|
|
gptkbp:producedBy
|
gptkb:testicles
adrenal glands
ovaries
|
|
gptkbp:proteinBinding
|
gptkb:sex_hormone-binding_globulin
albumin
|
|
gptkbp:regulates
|
gptkb:World_Anti-Doping_Agency
|
|
gptkbp:relatedTo
|
gptkb:progesterone
gptkb:dihydrotestosterone
estrogen
|
|
gptkbp:routeOfAdministration
|
oral
transdermal
intramuscular injection
subcutaneous injection
|
|
gptkbp:sideEffect
|
hair loss
infertility
aggression
acne
|
|
gptkbp:solubility
|
insoluble in water
soluble in alcohol
|
|
gptkbp:usedFor
|
performance enhancement
hormone replacement therapy
treatment of hypogonadism
|
|
gptkbp:bfsParent
|
gptkb:Tomasz_Karolak
|
|
gptkbp:bfsLayer
|
6
|